Details for New Drug Application (NDA): 019292
✉ Email this page to a colleague
NDA 019292 describes MD-76R, which is a drug marketed by Liebel-flarsheim and is included in one NDA. Additional details are available on the MD-76R profile page.
The generic ingredient in MD-76R is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
The generic ingredient in MD-76R is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
Summary for 019292
| Tradename: | MD-76R |
| Applicant: | Liebel-flarsheim |
| Ingredient: | diatrizoate meglumine; diatrizoate sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 66%;10% | ||||
| Approval Date: | Sep 29, 1989 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
